IRD

Opus Genetics
IRD

Overview Fund Trends Analyst Outlook Journalist POV

33 hedge funds and large institutions have $7.3M invested in Opus Genetics in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 2 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

Holders
33
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.5M
2
+$440K
3
+$229K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$191K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$86K

Top Sellers

1
-$1.04M
2
-$768K
3
-$15K
4
UBS Group
UBS Group
Switzerland
-$4K
5
TRCT
Tower Research Capital (TRC)
New York
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$5K
27
$4K
28
$2K
29
$1.03K
30
$1K
31
$1K
32
$1K
33
–
34
–
35
–
36
–
37
–
38
–
1
2